Healthcare · Healthcare Software
Benchling
Series F
Implied valuation
$00 B
Live tracking
IPO Odds00 %modeled estimate
Probability modeled from funding stage, momentum & liquidity signals.
Valuation Trajectory
959×
since foundingJun 2016Jun 2026
Funding-round staircase from founding · log scale. Modeled round ladder anchored to the current valuation — illustrative, not a published figure.
IPO Model Drivers
Why the odds read this way
Financing stage
Series FValuation momentum
+161.8% trailingScale & liquidity pull
Private-market valuationFactor weights are illustrative decompositions of the modeled IPO probability, not guarantees.
Down-Round Risk
Valuation downside pressure
Low
Strong momentum (limited valuation history) and a late financing stage make a down round unlikely near-term.
Asset brief
Benchling is a Healthcare · Healthcare Software company last marked at $6.1B. Stage: Series F. No verified market-moving events in the last 30 days.
Capital Timeline
Funding & liquidity milestones
Series F
$6.1B
Backed by
No disclosed investors yet.
Comparables
Healthcare
Signals
No recent signals for Benchling.